Post

New research · Obstetrics & Gynecology
The New England journal of medicine · 1d
Randomized trialThe New England journal of medicine · 2025

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Hua Tu, He Huang, Yanfang Li … PHENIX Investigators
Read paper
Obstetrics & GynecologyRandomized trial

Sentinel-lymph-node biopsy alone is noninferior for disease-free survival in early-stage cervical cancer.

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Hua Tu et al. · The New England journal of medicine · 2025
Background

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer.

Methods

Who had negative sentinel lymph nodes were intraoperatively assigned in a 1:1 ratio not to undergo pelvic lymphadenectomy (the biopsy-only group) or to undergo lymphadenectomy (the lymphadenectomy group).

n = 838 patients
Results

the chance of staying cancer-free for 3 years was higher with biopsy only

difference -2.30 (95% CI -5 to 0.50)
null = 0-50.50
CI crosses the null - not significant
More results

A total of 838 patients underwent randomization: 420 patients were assigned to the biopsy-only group and 418 to the lymphadenectomy group.

Retroperitoneal nodal recurrences occurred in no patients in the biopsy-only group and in 9 patients (2.2%) in the lymphadenectomy group.

“
Conclusion · 1 of 2

In patients with early-stage cervical cancer, sentinel-lymph-node biopsy alone was noninferior to lymphadenectomy with respect to disease-free survival and was associated with fewer complications.

Conclusion · 2 of 2

(Funded by Guangzhou Municipal Science and Technology and others; PHENIX ClinicalTrials.gov number, NCT02642471.).

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
HR 0.85
The hazard of death was similar with adjuvant chemoradiotherapy versus radiotherapy alone.
Randomized Trial
HR 0·42
for p53-abnormal tumors, combined treatment nearly halved the risk of cancer returning
Study
96.2% (90% CI, 85.9%-97.9%)
high percentage of patients whose hormone levels returned to normal, allowing treatment to stop
Cohort Study
95.3%
adding abdominal fat thickness improved the correct identification of gestational diabetes
Cohort Study
38.1%
patients with low-grade precancerous cervical lesions missing family doctor follow-up
Cohort Study
26.4%
women with diabetes during pregnancy developed high blood pressure 5 months after birth
Cohort Study
HR, 0.81
hormone therapy was associated with a better chance of living longer
Cohort Study
33.3%
Among pregnant women with anemia, a higher percentage had babies born early